Narjust Duma

7.1k total citations · 2 hit papers
95 papers, 3.3k citations indexed

About

Narjust Duma is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gender Studies. According to data from OpenAlex, Narjust Duma has authored 95 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 21 papers in Gender Studies. Recurrent topics in Narjust Duma's work include Diversity and Career in Medicine (18 papers), Lung Cancer Treatments and Mutations (14 papers) and Economic and Financial Impacts of Cancer (12 papers). Narjust Duma is often cited by papers focused on Diversity and Career in Medicine (18 papers), Lung Cancer Treatments and Mutations (14 papers) and Economic and Financial Impacts of Cancer (12 papers). Narjust Duma collaborates with scholars based in United States, United Kingdom and Mexico. Narjust Duma's co-authors include Julian R. Molina, Rafael Santana-Dávila, Jesus Vera Aguilera, Yucai Wang, Aaron S. Mansfield, Alex A. Adjei, Jonas Paludo, Þorvarður R. Hálfdánarson, Ronald S. Go and Konstantinos Leventakos and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Narjust Duma

86 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

2019 1.5k citations Narjust Duma, Rafael Santana-Dávila et al. Mayo Clinic Proceedings profile →
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials

2019 594 citations Narjust Duma, Julian R. Molina et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Narjust Duma United States	18	1.6k	1.2k	809	594	492	95	3.3k
Deborah Mukherji Lebanon	30	1.4k 0.9×	896 0.8×	1.2k 1.4×	652 1.1×	227 0.5×	183	3.4k
Catherine C. Lerro United States	8	1.3k 0.8×	698 0.6×	758 0.9×	474 0.8×	241 0.5×	18	2.9k
Andrew Lake United States	7	1.5k 1.0×	782 0.7×	768 0.9×	736 1.2×	180 0.4×	15	3.3k
Bhawna Sirohi India	33	1.7k 1.1×	792 0.7×	817 1.0×	514 0.9×	315 0.6×	171	3.8k
Jonathan M. Loree Canada	31	2.2k 1.4×	877 0.8×	745 0.9×	921 1.6×	385 0.8×	177	3.7k
Huiying Sun China	21	780 0.5×	1.2k 1.0×	1.1k 1.3×	631 1.1×	193 0.4×	97	2.9k
Paul G. Kluetz United States	34	1.8k 1.2×	1.3k 1.1×	579 0.7×	608 1.0×	321 0.7×	174	4.0k
Masashi Ando Japan	31	2.0k 1.3×	954 0.8×	688 0.9×	774 1.3×	203 0.4×	206	3.6k
Elena Garralda Spain	28	1.7k 1.1×	650 0.6×	674 0.8×	551 0.9×	249 0.5×	210	3.3k
Fengmin Zhao United States	29	2.0k 1.3×	752 0.6×	745 0.9×	607 1.0×	204 0.4×	77	3.0k

Countries citing papers authored by Narjust Duma

Since Specialization

Citations

This map shows the geographic impact of Narjust Duma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Narjust Duma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Narjust Duma more than expected).

Fields of papers citing papers by Narjust Duma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Narjust Duma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Narjust Duma. The network helps show where Narjust Duma may publish in the future.

Co-authorship network of co-authors of Narjust Duma

This figure shows the co-authorship network connecting the top 25 collaborators of Narjust Duma. A scholar is included among the top collaborators of Narjust Duma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Narjust Duma. Narjust Duma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Steiling, Katrina, Hasmeena Kathuria, Chidiebere Peter Echieh, et al.. (2023). Research Priorities for Interventions to Address Health Disparities in Lung Nodule Management: An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine. 207(6). e31–e46. 6 indexed citations

Vavra, Ashley K., Andres Guerra, Katherine Hekman, et al.. (2023). Unconscious bias in speaker introductions at a national vascular surgery meeting: The impact of rank, race and gender. The American Journal of Surgery. 232. 54–58. 2 indexed citations

Maximiano, Constanza, Blanca Cantos, María Torrente, et al.. (2023). Sexual dysfunction in patients with cancer, a challenge in oncology practice: results of the CLARIFY project. Clinical & Translational Oncology. 26(5). 1147–1156. 5 indexed citations

Dee, Edward Christopher, Idalid Franco, Neha Goel, et al.. (2022). Disparities in Primary Breast Cancer Stage at Presentation Among Hispanic Subgroups. Annals of Surgical Oncology. 29(13). 7977–7987. 14 indexed citations

Graff, Stephanie L., Tanya M. Wildes, Narjust Duma, et al.. (2022). Understanding Modern Medical Centers: Beyond Simone—Intersectional Maxims for a New Era. Journal of Clinical Oncology. 41(7). 1350–1358. 1 indexed citations

Schild, Steven E., Christine M. Bestvina, Terence M. Williams, et al.. (2022). Alliance A082002 -a randomized phase II/III trial of modern immunotherapy-based systemic therapy with or without SBRT for PD-L1-negative, advanced non-small cell lung cancer. Clinical Lung Cancer. 23(5). e317–e320. 12 indexed citations

Franco, Idalid, Bhav Jain, Kenrick Ng, et al.. (2022). Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men. Prostate Cancer and Prostatic Diseases. 26(2). 309–316. 17 indexed citations

Dhawan, Natasha, Molly Carnes, Angela Byars‐Winston, & Narjust Duma. (2021). Videoconferencing Etiquette: Promoting Gender Equity During Virtual Meetings. Journal of Women s Health. 30(4). 460–465. 13 indexed citations

Marshall, Ariela L., Melissa A. Elafros, & Narjust Duma. (2021). Work Patterns of Women Physicians During Vacation: A Cross-Sectional Study. Journal of Women s Health. 31(4). 573–579. 3 indexed citations

10.

Godecker, Amy, et al.. (2021). Professional Address during Obstetrics and Gynecology Grand Rounds Introductions: Setting the Stage, Setting the Standard. Journal of surgical education. 78(6). 1930–1937. 1 indexed citations

11.

Albitar, Hasan Ahmad Hasan, Narjust Duma, Konstantinos Leventakos, & Alice Gallo de Moraes. (2020). Pulmonary Complications Secondary to Immune Checkpoint Inhibitors. SHILAP Revista de lepidopterología. 2020. 1–5. 3 indexed citations

12.

Brown, Sherry‐Ann, Narjust Duma, Eric H. Yang, et al.. (2020). Leveraging Social Media for Cardio-Oncology. Current Treatment Options in Oncology. 21(10). 83–83. 13 indexed citations

13.

Velázquez, Ana I., et al.. (2020). The HOLA COVID-19 Study: An International Effort to Determine How COVID-19 Has Impacted Oncology Practices in Latin America. Cancer Cell. 38(5). 605–608. 3 indexed citations

14.

Carr, Ryan M., Narjust Duma, Angela L. McCleary‐Wheeler, et al.. (2020). Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination. Pancreatology. 20(6). 1115–1122. 17 indexed citations

15.

Shah, Kanan, C. Jillian Tsai, Miriam A. Knoll, et al.. (2020). Evaluating Bias in Speaker Introductions at the American Society for Radiation Oncology Annual Meeting. International Journal of Radiation Oncology*Biology*Physics. 110(2). 303–311. 11 indexed citations

16.

Duma, Narjust, Rafael Santana-Dávila, & Julian R. Molina. (2019). Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. Mayo Clinic Proceedings. 94(8). 1623–1640. 1507 indexed citations breakdown →

17.

Ruddy, Kathryn J., Lindsey R. Sangaralingham, Rachel A. Freedman, et al.. (2018). Adherence to Guidelines for Breast Surveillance in Breast Cancer Survivors. Journal of the National Comprehensive Cancer Network. 16(5). 526–534. 18 indexed citations

18.

Duma, Narjust, et al.. (2018). Where Do We Stand on the Integration of PARP Inhibitors for the Treatment of Breast Cancer?. Current Oncology Reports. 20(8). 63–63. 3 indexed citations

19.

Duma, Narjust. (2016). Gastric Adenocarcinoma: Clinicopathologic differences among Hispanics and Non-Hispanic Whites. A Single Institution’s Experience over 14 Years. Annals of Gastroenterology. 29(3). 325–31. 12 indexed citations

20.

Duma, Narjust, et al.. (2015). Bone Marrow Involvementas the Initial Presentation of Breast Cancer. American Journal of Medical Case Reports. 3(6). 177–180. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact